GC Cell Corporation

KOSDAQ:A144510 Stock Report

Market Cap: ₩211.1b

GC Cell Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for GC Cell.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth22.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article • Nov 05

GC Cell Corporation (KOSDAQ:144510) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

The GC Cell Corporation ( KOSDAQ:144510 ) share price has done very well over the last month, posting an excellent gain...
Analysis Article • Oct 31

GC Cell (KOSDAQ:144510) Is Making Moderate Use Of Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Apr 09

Benign Growth For GC Cell Corporation (KOSDAQ:144510) Underpins Stock's 26% Plummet

Unfortunately for some shareholders, the GC Cell Corporation ( KOSDAQ:144510 ) share price has dived 26% in the last...
Analysis Article • Dec 01

The Market Doesn't Like What It Sees From GC Cell Corporation's (KOSDAQ:144510) Revenues Yet As Shares Tumble 27%

The GC Cell Corporation ( KOSDAQ:144510 ) share price has fared very poorly over the last month, falling by a...
Analysis Article • Oct 14

Revenues Working Against GC Cell Corporation's (KOSDAQ:144510) Share Price

GC Cell Corporation's ( KOSDAQ:144510 ) price-to-sales (or "P/S") ratio of 2.8x might make it look like a strong buy...
Analysis Article • Sep 08

Is GC Cell (KOSDAQ:144510) A Risky Investment?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Mar 19

We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative

When companies post strong earnings, the stock generally performs well, just like Green Cross Lab Cell Corporation's...
Analysis Article • Feb 22

We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Jan 18

Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Analysis Article • Dec 14

Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?

Unless you borrow money to invest, the potential losses are limited. But if you pick the right stock, you can make a...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as GC Cell has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A144510 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2026163,347-257,9772,0507,913N/A
12/31/2025165,523-272,8593,1709,193N/A
9/30/2025170,132-98,193-1,2991,582N/A
6/30/2025170,465-85,292-6,680-2,920N/A
3/31/2025172,917-82,244-3,372730N/A
12/31/2024174,451-73,9006,36311,342N/A
9/30/2024184,356-3,388-8,716-3,026N/A
6/30/2024184,444-10,708-5,0601,708N/A
3/31/2024186,623-6,802-7,6383,500N/A
12/31/2023187,544-174-13,9473,671N/A
9/30/2023182,085-10,813-4,06316,822N/A
6/30/2023186,192-6,589-9,23810,940N/A
3/31/2023194,327-94615,69535,156N/A
12/31/2022236,12026,53752,63666,415N/A
9/30/2022262,62151,81943,88056,213N/A
6/30/2022251,38252,69043,32156,899N/A
3/31/2022224,84850,93923,21236,636N/A
12/31/2021168,31031,42210,18923,908N/A
9/30/2021121,23115,40412,61624,339N/A
6/30/2021106,8108,73317,69127,747N/A
3/31/202197,6199,51816,53924,599N/A
12/31/202085,5624,1602,9549,094N/A
9/30/202075,0832,256-8296,873N/A
6/30/202065,762599-5,8161,120N/A
3/31/202060,762-1,670-6,396-1,135N/A
12/31/201957,895-2,276N/A223N/A
9/30/201955,920-421N/A-1,002N/A
12/31/201850,6201,002N/A491N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A144510's forecast earnings growth is above the savings rate (3.1%).

Earnings vs Market: Insufficient data to determine if A144510's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A144510's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A144510's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A144510's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A144510's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 00:53
End of Day Share Price 2026/07/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

GC Cell Corporation is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jinhee KwakEugene Investment & Securities Co Ltd.
Seung-Ho LeeNH Investment & Securities Co., Ltd.